Andrew Regan - Net Worth and Insider Trading
Andrew Regan Net Worth
The estimated net worth of Andrew Regan is at least $2 Million dollars as of 2024-11-05. Andrew Regan is the Director, 10% Owner of Conduit Pharmaceuticals Inc and owns about 15,722,972 shares of Conduit Pharmaceuticals Inc (CDT) stock worth over $2 Million. Details can be seen in Andrew Regan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Regan has not made any transactions after 2024-07-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew Regan
Andrew Regan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Regan owns 1 companies in total, including Conduit Pharmaceuticals Inc (CDT) .
Click here to see the complete history of Andrew Regan’s form 4 insider trades.
Insider Ownership Summary of Andrew Regan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CDT | Conduit Pharmaceuticals Inc | 2024-07-17 | director & 10 percent owner |
Andrew Regan Latest Holdings Summary
Andrew Regan currently owns a total of 1 stock. Andrew Regan owns 15,722,972 shares of Conduit Pharmaceuticals Inc (CDT) as of July 17, 2024, with a value of $2 Million.
Latest Holdings of Andrew Regan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CDT | Conduit Pharmaceuticals Inc | 2024-07-17 | 15,722,972 | 0.11 | 1,654,057 |
Holding Weightings of Andrew Regan
Andrew Regan Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Regan has made a total of 1 transactions in Conduit Pharmaceuticals Inc (CDT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Conduit Pharmaceuticals Inc is the sale of 15,301,068 shares on July 17, 2024, which brought Andrew Regan around $5 Million.
Insider Trading History of Andrew Regan
- 1
Andrew Regan Trading Performance
Andrew Regan Ownership Network
Ownership Network List of Andrew Regan
Ownership Network Relation of Andrew Regan
Andrew Regan Owned Company Details
What does Conduit Pharmaceuticals Inc do?
Who are the key executives at Conduit Pharmaceuticals Inc?
Andrew Regan is the director & 10 percent owner of Conduit Pharmaceuticals Inc. Other key executives at Conduit Pharmaceuticals Inc include 10 percent owner & other: See Responses Corvus Capital Ltd. , 10 percent owner & other: See Responses Algo Holdings, Inc. , and director & Chief Executive Officer David Tapolczay .
Conduit Pharmaceuticals Inc (CDT) Insider Trades Summary
Over the past 18 months, Andrew Regan made 1 insider transaction in Conduit Pharmaceuticals Inc (CDT) with a net sale of 15,301,068. Other recent insider transactions involving Conduit Pharmaceuticals Inc (CDT) include a net sale of 6,408,000 shares made by ,
In summary, during the past 3 months, insiders sold 6,408,000 shares of Conduit Pharmaceuticals Inc (CDT) in total and bought 0 shares, with a net sale of 6,408,000 shares. During the past 18 months, 21,709,068 shares of Conduit Pharmaceuticals Inc (CDT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 21,709,068 shares.
Conduit Pharmaceuticals Inc (CDT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Conduit Pharmaceuticals Inc Insider Transactions
Andrew Regan Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Regan. You might contact Andrew Regan via mailing address: Le Manoir De Lurin, Saint Barthelemy Z0 97133.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
